IV
Inventiva S.A.
IVEVF · OTC
$3.59 +0.00% (+$0.00)
Market Cap 734.1M €
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 163.82x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 28.34%
EPS growth N/A
FCF growth N/A
Profitability
14 /100
Weak Gross margin 35.07%
Net margin 7,899.58%
FCF margin 2,345.98%
Quality
0 /100
Poor ROIC 64.58%
ROA 141.88%
Asset turnover 0.02x
Debt
43 /100
Moderate Current ratio 3.16x
Int. coverage -4.06x
Debt/Equity N/A
Stability
32 /100
Unstable Beta 0.91x
Rev. volatility 56.55%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IVEVF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Andrew Obenshain
Employees
77
Headquarters
Daix
Upcoming events
28 SEP
Earnings
Upcoming earnings report